News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) To Webcast Post American Society of Hematology Investor Seminar


12/5/2013 9:29:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; December 5, 2013 – Genmab A/S (OMX: GEN) will webcast its Post ASH investor seminar focused on the company’s latest developments in antibody innovation on December 10, 2013 from 7:30PM to 9:30PM CET. At the seminar key opinion leaders will discuss and put into perspective data from studies of ofatumumab and daratumumab presented at the 2013 Annual Meeting of the American Society of Hematology (ASH) and Genmab will provide information on progress with the company’s proprietary antibody technologies, and expected performance milestones for 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES